An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Overview of attention for article published in Trials, November 2017

Altmetric Badge

Mentioned by

policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 96 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

TB notes ; 2018, no. 2

Cited by Centers for Disease Control and Prevention (CDC) on 01 Jan 2018

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

TB notes ; 2018, no. 1

Cited by Centers for Disease Control and Prevention (CDC) on 01 Jan 2018

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.